Skip to main content

Table 2 Multivariate analysis of survival for IDO1 protein in the Yale hormone-receptor positive breast cancer collection

From: Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

 

20-year OS

 

HR

(95% C.I.)

P value

Age > 50 years

2.26

(1.59-3.39)

< 0.0001

Tumor size >2 cm

2.11

(1.59-2.81)

< 0.0001

Lymph node positive status

1.43

(1.00-2.01)

0.05

TNM Stage III

1.02

(0.67-1.56)

0.91

IDO1-high status

1.57

(1.19-2.09)

0.002

Back to article page